Overall rank by patents
#34,143
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, active 2020–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B65F (GATHERING OR REMOVAL OF DOMESTIC OR LIKE REFUSE).
The verdict
Angelcare holds 7 US patents across 4 technology areas, rank #34,143 of 50,000 tracked assignees.
Angelcare USA, Llc has been granted 7 US utility patents between 2020 and 2023, placing Angelcare USA, Llc at rank #34,143 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.4 claims per patent with primary concentration in B65F (GATHERING OR REMOVAL OF DOMESTIC OR LIKE REFUSE). As a US Corporation, Angelcare USA, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Angelcare sits between Amtai Medical Equipment, Inc (7 patents, rank #34,139) and Anhui University OF Technology (7 patents, rank #34,147) - the closest US assignees by grant volume. The composite Innovation Score of 22.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2023, with 7 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Angelcare USA, Llc's 11.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Angelcare USA, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AMTAI MEDICAL EQUIPMENT, INC
7 patents
ANAGLOBE TECHNOLOGY, INC.
7 patents
ANANDA DEVICES, INC.
7 patents
ANASTASIA BEVERLY HILLS, LLC
7 patents
ANGLE EUROPE LIMITED
7 patents
ANGLO AMERICAN SERVICES (UK) LTD
7 patents
ANHO HOUSEWARE CO., LTD. JIANGMEN
7 patents
ANHUI UNIVERSITY OF TECHNOLOGY
7 patents
ANGELCARE USA, LLC
7 patents
What this shows Angelcare holds 7 patents at rank #34,143, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #34,143 in granted patent volume.
Other assignees with the most granted patents in Angelcare's primary technology class.
Angelcare's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
22 Top 90% higher than 10% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 5 | 71.4% |
| 2021 | 1 | 14.3% |
| 2023 | 1 | 14.3% |
Top 4 of 4 technology areas
Overall rank by patents
#34,143
Across all tracked assignees
22.2 out of 100
How to use this portfolio
Angelcare's 7 grants land it in the top 90% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.